HERB-INDUCED OXIDANT PRECONDITIONING IN CARDIOMYOCYTES

草药诱导的心肌细胞氧化预处理

基本信息

  • 批准号:
    7470953
  • 负责人:
  • 金额:
    $ 23.4万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-05-01 至 2011-04-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): This proposal builds upon work suggesting that the herbal extract Scutellaria baicalensis (SbE) and its major component baicalein may simulate many important components of cardiac preconditioning (PC), i.e. trigger transient mitochondrial oxidant signaling, activate the survival kinase Akt, attenuate reperfusion reactive oxygen species (ROS) and increase reperfusion nitric oxide (NO) generation. It is one of the few PC compounds we have tested that provides significant protection in 3 lethal models of cardiac ischemia/ reperfusion (I/R): chick cardiomyocytes, murine cardiomyocytes and murine cardiac arrest. An herbal extract already used in popular alternative medicine has practical advantages for use as a pharmacologic cardiac PC agent in patients at risk for adverse cardiac events. This proposal seeks to further examine PC protection induced by SbE and/or baicalein in murine cardiomyocytes by determining the mechanisms involved in generating the protective phenotype. We hypothesize that SbE and/or baicalein will induce PC protection against murine cardiomyocyte I/R injury via a transient ROS generation that initiates the activation of PKCe and/or Akt resulting in eNOS activation and increased reperfusion NO generation. Specifically, Aim 1 will optimize the dose of SbE and/or baicalein that trigger ROS-mediated PC, and determine the source and importance of these ROS using various antioxidants and mitochondrial inhibitors. Further, we will test whether these transient ROS induce augmented reperfusion NO and protection against apoptosis. In Aim 2, we will evaluate the pathway by which the most effective herb-induced PC protocol confers protection. We will assess the activation of PKCe and/or Akt in herb-induced PC using PKCe translocation, Akt phosphorylation, and Akt activity. We also will examine the role of ROS in inducing PKCe and/or Akt activation and the effect of this kinase activation on eNOS phosphorylation and NO generation using kinase inhibitors, siRNA gene silencing and knockout strategies for eNOS and Akt-1. These results will help clarify important PC pathways in murine cardiomyocytes, focusing on how mitochondrial oxidants, certain stress kinases, and eNOS may interact to protect against I/R injury. This work will be used to plan translational studies of herb-PC into our mouse model of cardiac arrest. Finally, a better understanding of SbE- and/or baicalein PC could lead to new oxidant-mediated PC clinical therapies. PUBLIC HEALTH RELEVANCE: From a layperson perspective, there are few medicines that protect against future heart attacks. In addition, many studies of herb compounds as alternative medicines have focused on their antioxidant effects. This proposal will study an herb mixture that actually increases a type of oxidant stress in the heart that may help condition it and protect against future heart attack injury.
描述(由申请人提供):该提案建立在以下工作的基础上,该工作表明草药提取物黄芩(SbE)及其主要成分黄芩素可以模拟心脏预处理(PC)的许多重要成分,即触发瞬时线粒体氧化剂信号传导,激活存活激酶Akt,减弱再灌注活性氧(ROS)并增加再灌注一氧化氮(NO)生成。它是我们测试的少数PC化合物之一,在3种致死性心脏缺血/再灌注(I/R)模型中提供显著保护:鸡心肌细胞,小鼠心肌细胞和小鼠心脏骤停。一种已经在流行的替代医学中使用的草药提取物具有实际优势,可用作具有不良心脏事件风险的患者的药理学心脏PC剂。该建议旨在通过确定产生保护性表型的机制来进一步检查由SbE和/或黄芩素诱导的小鼠心肌细胞中的PC保护。我们假设,SbE和/或黄芩素将诱导PC保护小鼠心肌细胞I/R损伤,通过短暂的ROS产生,启动激活PKCe和/或Akt,导致eNOS激活和再灌注NO产生增加。具体而言,目标1将优化触发ROS介导的PC的SbE和/或黄芩素的剂量,并使用各种抗氧化剂和线粒体抑制剂确定这些ROS的来源和重要性。此外,我们将测试这些短暂的ROS是否诱导再灌注NO增加和抗细胞凋亡的保护。在目标2中,我们将评估最有效的草药诱导PC方案提供保护的途径。我们将使用PKCe易位、Akt磷酸化和Akt活性评估草药诱导的PC中PKCe和/或Akt的活化。我们还将研究ROS在诱导PKCe和/或Akt激活中的作用,以及这种激酶激活对eNOS磷酸化和NO生成的影响,使用激酶抑制剂,siRNA基因沉默和eNOS和Akt-1敲除策略。这些结果将有助于阐明小鼠心肌细胞中重要的PC途径,重点是线粒体氧化剂,某些应激激酶和eNOS如何相互作用,以防止I/R损伤。这项工作将用于计划将herb-PC转化为我们的小鼠心脏骤停模型的研究。最后,更好地了解SbE-和/或黄芩素PC可能导致新的氧化剂介导的PC临床治疗。公共卫生相关性:从外行的角度来看,很少有药物可以预防未来的心脏病发作。此外,许多草药化合物作为替代药物的研究都集中在其抗氧化作用上。这项提案将研究一种草药混合物,实际上增加了一种类型的氧化应激的心脏,可能有助于条件,并防止未来的心脏病发作伤害。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Zuo-hui Shao其他文献

Zuo-hui Shao的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Zuo-hui Shao', 18)}}的其他基金

HERB-INDUCED OXIDANT PRECONDITIONING IN CARDIOMYOCYTES
草药诱导的心肌细胞氧化预处理
  • 批准号:
    8433844
  • 财政年份:
    2009
  • 资助金额:
    $ 23.4万
  • 项目类别:
HERB-INDUCED OXIDANT PRECONDITIONING IN CARDIOMYOCYTES
草药诱导的心肌细胞氧化预处理
  • 批准号:
    7841950
  • 财政年份:
    2009
  • 资助金额:
    $ 23.4万
  • 项目类别:
Herbs Protect against Doxorubicin-induced Cardiotoxicity
草药可预防阿霉素引起的心脏毒性
  • 批准号:
    6570360
  • 财政年份:
    2002
  • 资助金额:
    $ 23.4万
  • 项目类别:
Herbs Protect against Doxorubicin-induced Cardiotoxicity
草药可预防阿霉素引起的心脏毒性
  • 批准号:
    6657313
  • 财政年份:
    2002
  • 资助金额:
    $ 23.4万
  • 项目类别:

相似海外基金

Enhancing gamete cryoprotective properties of graphene oxide by dual functionalization with antioxidants and non-penetrating cryoprotectant molecules
通过抗氧化剂和非渗透性冷冻保护剂分子的双重功能化增强氧化石墨烯的配子冷冻保护特性
  • 批准号:
    24K18002
  • 财政年份:
    2024
  • 资助金额:
    $ 23.4万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
SBIR Phase I: Sustainable antioxidants for industrial process fluids
SBIR 第一阶段:工业过程流体的可持续抗氧化剂
  • 批准号:
    2222215
  • 财政年份:
    2023
  • 资助金额:
    $ 23.4万
  • 项目类别:
    Standard Grant
Development of a new bone augmentation method that enables long-term survival and long-term functional expression of transplanted cells by antioxidants
开发一种新的骨增强方法,通过抗氧化剂使移植细胞能够长期存活和长期功能表达
  • 批准号:
    23K09272
  • 财政年份:
    2023
  • 资助金额:
    $ 23.4万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Non-Invasive Probing Cellular Oxidative Stress and Antioxidants Therapeutic Effectiveness
非侵入性探测细胞氧化应激和抗氧化剂的治疗效果
  • 批准号:
    10652764
  • 财政年份:
    2023
  • 资助金额:
    $ 23.4万
  • 项目类别:
Mitochondria-targeting Novel Cationic Hydrazone Antioxidants for the Treatment of Preeclampsia
线粒体靶向新型阳离子腙抗氧化剂用于治疗先兆子痫
  • 批准号:
    10730652
  • 财政年份:
    2023
  • 资助金额:
    $ 23.4万
  • 项目类别:
Latent Antioxidants for Environmentally Responsible Polymer Formulations
用于环保聚合物配方的潜在抗氧化剂
  • 批准号:
    RGPIN-2018-04107
  • 财政年份:
    2022
  • 资助金额:
    $ 23.4万
  • 项目类别:
    Discovery Grants Program - Individual
Contribution of antioxidants to regeneration of rotator cuff insertion
抗氧化剂对肩袖插入再生的贡献
  • 批准号:
    22K16720
  • 财政年份:
    2022
  • 资助金额:
    $ 23.4万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Effects of different doses of antioxidants(Vitamin E) intake on exercise induced oxidative stress, antioxidative capacity and chronic inflammation
不同剂量抗氧化剂(维生素E)摄入对运动引起的氧化应激、抗氧化能力和慢性炎症的影响
  • 批准号:
    22K11609
  • 财政年份:
    2022
  • 资助金额:
    $ 23.4万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Polyunsaturated fatty acid (PUFA), inflammation and antioxidants
多不饱和脂肪酸 (PUFA)、炎症和抗氧化剂
  • 批准号:
    RGPIN-2019-05674
  • 财政年份:
    2022
  • 资助金额:
    $ 23.4万
  • 项目类别:
    Discovery Grants Program - Individual
Suppressed methemoglobin formation of artificial red cell by liposomal antioxidants and its mechanism.
脂质体抗氧化剂抑制人工红细胞高铁血红蛋白形成及其机制
  • 批准号:
    22K12824
  • 财政年份:
    2022
  • 资助金额:
    $ 23.4万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了